Ngā hua rapu - Deborah Toppmeyer
- E whakaatu ana i te 1 - 18 hua o te 18
-
1
-
2
-
3
-
4
Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients mā Sibo Tian, Kim M. Hirshfield, Salma K. Jabbour, Deborah Toppmeyer, Bruce G. Haffty, Atif J. Khan, Sharad Goyal
I whakaputaina 2014Revisão -
5
Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer mā Bruce G. Haffty, Qifeng Yang, Michael Reiß, Thomas Kearney, Susan A. Higgins, Joanne B. Weidhaas, Lyndsay N. Harris, Willam Hait, Deborah Toppmeyer
I whakaputaina 2006Artigo -
6
Hypofractionated Postmastectomy Radiation Therapy Is Safe and Effective: First Results From a Prospective Phase II Trial mā Atif J. Khan, Matthew M. Poppe, Sharad Goyal, Kristine E. Kokeny, Thomas Kearney, Laurie Kirstein, Deborah Toppmeyer, Dirk F. Moore, Chunxia Chen, David K. Gaffney, Bruce G. Haffty
I whakaputaina 2017Artigo -
7
Randomized Phase III Trial of Paclitaxel Once Per Week Compared With Nanoparticle Albumin-Bound Nab-Paclitaxel Once Per Week or Ixabepilone With Bevacizumab As First-Line Chemother... mā Hope S. Rugo, William T. Barry, Alvaro Moreno‐Aspitia, Alan P. Lyss, Constance Cirrincione, Eleanor H. Leung, Erica L. Mayer, Michael Naughton, Deborah Toppmeyer, Lisa A. Carey, Edith A. Perez, Clifford A. Hudis, Eric P. Winer
I whakaputaina 2015Artigo -
8
Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma mā Sunniva Bjørklund, Anshuman Panda, Surendra Kumar, Michael Seiler, Doug Robinson, Jinesh S. Gheeya, Yao Ming, Grethe I.G. Alnæs, Deborah Toppmeyer, Margit Riis, Bjørn Naume, Anne‐Lise Børresen‐Dale, Vessela N. Kristensen, Shridar Ganesan, Gyan Bhanot
I whakaputaina 2017Artigo -
9
Relationship between tumor infiltrating lymphocyte (TIL) levels and response to pembrolizumab (pembro) in metastatic triple-negative breast cancer (mTNBC): Results from KEYNOTE-086 mā Sherene Loi, Sylvia Adams, Peter Schmid, Javier Cortés, David W. Cescon, Eric P. Winer, Deborah Toppmeyer, Hope S. Rugo, Michelino De Laurentiis, Rita Nanda, Hiroji Iwata, Ahmad Awada, Antoinette R. Tan, A. Wang, Gursel Aktan, Vassiliki Karantza, Roberto Salgado
I whakaputaina 2017Artigo -
10
Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study mā Sylvia Adams, Sherene Loi, Deborah Toppmeyer, David W. Cescon, Michelino De Laurentiis, Rita Nanda, Eric P. Winer, Hirofumi Mukai, Kenji Tamura, Anne Armstrong, M.C. Liu, Hiroji Iwata, L Ryvo, Pauline Wimberger, Hope S. Rugo, Antoinette R. Tan, Lin Jia, Yu Ding, Vassiliki Karantza, Peter Schmid
I whakaputaina 2018Artigo -
11
TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM tria... mā Nadine Tung, Banu K. Arun, Michele R. Hacker, Erin Hofstatter, Deborah Toppmeyer, Steven J. Isakoff, Virginia F. Borges, Robert D. Legare, Claudine Isaacs, Antonio C. Wolff, P. Kelly Marcom, Erica L. Mayer, Paulina Lange, Andrew J. Goss, C. David Jenkins, Ian E. Krop, Eric P. Winer, Stuart J. Schnitt, Judy E. Garber
I whakaputaina 2020Artigo -
12
Assessment of Diagnostic Outcomes of RNA Genetic Testing for Hereditary Cancer mā Rachid Karam, Blair R. Conner, Holly LaDuca, Kelly McGoldrick, Kate Krempely, Marcy E. Richardson, Heather Zimmermann, Stephanie Gutierrez, Patrick Reineke, Lily Hoang, Kyle Allen, Amal Yussuf, Suzette Farber-Katz, Huma Q. Rana, Samantha Culver, John Lee, Sarah Nashed, Deborah Toppmeyer, Debra L. Collins, Ginger Haynes, Tina Pesaran, Jill S. Dolinsky, Brigette Tippin Davis, Aaron Elliott, Elizabeth Chao
I whakaputaina 2019Artigo -
13
Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy mā Joseph A. Sparano, Robert J. Gray, Della Makower, Kathy S. Albain, Thomas J. Saphner, Sunil Badve, Lynne I. Wagner, Virginia Kaklamani, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Deborah Toppmeyer, Adam Brufsky, Matthew P. Goetz, Jeffrey L. Berenberg, Catalin Mahalcioiu, Christine Desbiens, Daniel F. Hayes, Elizabeth Claire Dees, Charles E. Geyer, John A. Olson, William C. Wood, Tracy Lively, Soonmyung Paik, Matthew J. Ellis, Jeffrey S. Abrams, George W. Sledge
I whakaputaina 2019Artigo -
14
Race, Ethnicity, and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer in the Randomized TAILORx Trial mā Kathy S. Albain, Robert J. Gray, Della Makower, Amir Faghih, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, William C. Wood, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge, Joseph A. Sparano
I whakaputaina 2020Artigo -
15
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer mā Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge
I whakaputaina 2018Artigo -
16
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer mā Joseph A. Sparano, Robert J. Gray, Peter M. Ravdin, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Matthew P. Goetz, John A. Olson, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, Jeffrey L. Berenberg, Jeffrey S. Abrams, George W. Sledge
I whakaputaina 2019Artigo -
17
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer mā Joseph A. Sparano, Robert J. Gray, Della Makower, Kathleen I. Pritchard, Kathy S. Albain, Daniel F. Hayes, Charles E. Geyer, Elizabeth Claire Dees, Edith A. Perez, John A. Olson, JoAnne Zujewski, Tracy Lively, Sunil Badve, Thomas J. Saphner, Lynne I. Wagner, Timothy J. Whelan, Matthew J. Ellis, Soonmyung Paik, William C. Wood, Peter M. Ravdin, Maccon Keane, Henry Gómez, Pavan S. Reddy, Timothy F. Goggins, Ingrid A. Mayer, Adam Brufsky, Deborah Toppmeyer, Virginia Kaklamani, James N. Atkins, Jeffrey L. Berenberg, George W. Sledge
I whakaputaina 2015Artigo -
18
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line Chemotherapy mā Mark Jesus M. Magbanua, Laura H. Hendrix, Terry Hyslop, William T. Barry, Eric P. Winer, Clifford A. Hudis, Deborah Toppmeyer, Lisa A. Carey, Ann H. Partridge, Jean‐Yves Pierga, Tanja Fehm, José Vidal-Martínez, Dimitriοs Mavroudis, José Á. García-Sáenz, Justin Stebbing, Paola Gazzaniga, Luís Manso, Rita Zamarchi, María Luisa Antelo, Leticia De Mattos‐Arruda, Daniele Generali, Carlos Caldas, Elisabetta Munzone, Luc Dirix, Amy L. Delson, Harold J. Burstein, Misbah Qadir, X. Cynthia, Janet H. Scott, François‐Clément Bidard, John W. Park, Hope S. Rugo
I whakaputaina 2020Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Cancer
Breast cancer
Internal medicine
Medicine
Oncology
Chemotherapy
Biology
Metastatic breast cancer
Triple-negative breast cancer
Gene
Genetics
Adjuvant
Biochemistry
Bioinformatics
Biomarker
Chemistry
Clinical endpoint
Cohort
Confidence interval
Gene expression
Hazard ratio
Immunotherapy
Randomized controlled trial
Adjuvant chemotherapy
Anthracycline
Botany
Cancer research
Clinical trial
Cyclophosphamide
Docetaxel